Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery
- PMID: 21456532
- PMCID: PMC3878859
- DOI: 10.1021/bc1004526
Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery
Abstract
A series of charge-reversal lipids were synthesized that possess varying chain lengths and end functionalities. These lipids were designed to bind and then release DNA based on a change in electrostatic interaction with DNA. Specifically, a cleavable ester linkage is located at the ends of the hydrocarbon chains. The DNA release from the amphiphile was tuned by altering the length and position of the ester linkage in the hydrophobic chains of the lipids through the preparation of five new amphiphiles. The amphiphiles and corresponding lipoplexes were characterized by DSC, TEM, and X-ray, as well as evaluated for DNA binding and DNA transfection. For one specific charge-reversal lipid, stable lipoplexes of approximately 550 nm were formed, and with this amphiphile, effective in vitro DNA transfection activities was observed.
Figures














Similar articles
-
Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery.J Am Chem Soc. 2007 Sep 19;129(37):11408-20. doi: 10.1021/ja0704683. Epub 2007 Aug 25. J Am Chem Soc. 2007. PMID: 17718562
-
The effect of charge-reversal amphiphile spacer composition on DNA and siRNA delivery.Bioconjug Chem. 2010 May 19;21(5):988-93. doi: 10.1021/bc9005464. Bioconjug Chem. 2010. PMID: 20433165 Free PMC article.
-
Synthesis and transfection efficiency of cationic oligopeptide lipids: role of linker.Bioconjug Chem. 2011 Nov 16;22(11):2244-54. doi: 10.1021/bc2002874. Epub 2011 Oct 26. Bioconjug Chem. 2011. PMID: 21985175
-
Cationic lipids: molecular structure/ transfection activity relationships and interactions with biomembranes.Top Curr Chem. 2010;296:51-93. doi: 10.1007/128_2010_67. Top Curr Chem. 2010. PMID: 21504100 Review.
-
Gene delivery by lipoplexes and polyplexes.Eur J Pharm Sci. 2010 Jun 14;40(3):159-70. doi: 10.1016/j.ejps.2010.03.019. Epub 2010 Mar 30. Eur J Pharm Sci. 2010. PMID: 20359532 Review.
Cited by
-
Chemical oxidation of a redox-active, ferrocene-containing cationic lipid: influence on interactions with DNA and characterization in the context of cell transfection.J Colloid Interface Sci. 2012 Dec 1;387(1):56-64. doi: 10.1016/j.jcis.2012.07.083. Epub 2012 Aug 7. J Colloid Interface Sci. 2012. PMID: 22980739 Free PMC article.
-
Incorporation of DOPE into Lipoplexes formed from a Ferrocenyl Lipid leads to Inverse Hexagonal Nanostructures that allow Redox-Based Control of Transfection in High Serum.Soft Matter. 2012 Jan 1;8(24):2608-2619. doi: 10.1039/C2SM00047D. Epub 2012 May 17. Soft Matter. 2012. PMID: 22707977 Free PMC article.
-
Functional lipids and lipoplexes for improved gene delivery.Biochimie. 2012 Jan;94(1):42-58. doi: 10.1016/j.biochi.2011.05.005. Epub 2011 May 20. Biochimie. 2012. PMID: 21621581 Free PMC article. Review.
-
Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery.Acc Chem Res. 2012 Jul 17;45(7):1026-38. doi: 10.1021/ar200228y. Epub 2012 Mar 22. Acc Chem Res. 2012. PMID: 22439686 Free PMC article.
-
A Study of the Cellular Uptake of Magnetic Branched Amphiphilic Peptide Capsules.Mol Pharm. 2020 Jun 1;17(6):2208-2220. doi: 10.1021/acs.molpharmaceut.0c00393. Epub 2020 May 11. Mol Pharm. 2020. PMID: 32324415 Free PMC article.
References
-
- Deregowski P, Canalis E. Gene delivery by retroviruses. Methods in Molecular Biology. 2008;455:157–162. - PubMed
-
- Flotte TR. Gene therapy progress and prospects: Recombinant adeno-associated virus (rAAV) vectors. Gene Therapy. 2004;11:805–810. - PubMed
-
- Lundstrom K. Gene therapy applications of viral vectors. Technology in Cancer Research & Treatment. 2004;3:467–477. - PubMed
-
- Flotte TR. Gene therapy: The first two decades and the current state-of-the-art. J Cellular Physiology. 2007;213:301–305. - PubMed
-
- Ozawa K. Gene therapy using AAV vectors. Drug Del System. 2007;22:643–650.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources